Search
ProQR Therapeutics NV
PRQRAdd to Watchlist
1.810USD
+0.060+3.43%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
194.96MMarket Cap
LossP/E TTM
ProQR Therapeutics NV Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
18.82M
-11.29%
EPS(YoY)
-0.47
-40.88%
Analyst Rating
BUY
2026-07-05
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its total revenue reached 18.82M, with a year-on-year change of -11.29.
What are the current assets of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its current assets were 115.24M, with a year-on-year change of -30.97.
What are the total assets of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its total assets of ProQR Therapeutics NV were 129.78M, with a year-on-year change of -28.80.
What are the total liabilities of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its total liabilities of ProQR Therapeutics NV were 72.95M, with a year-on-year change of -15.33.
What is the total equity of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its total equity of ProQR Therapeutics NV was 56.83M, with a year-on-year change of -40.87.
What is the net investment of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its net investment of ProQR Therapeutics NV was -1.17M, with a year-on-year change of 73.44.
What is the net financing of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its net financing of ProQR Therapeutics NV was -2.11M, with a year-on-year change of -102.77.
What is the Earnings Per Share (EPS) of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its Earnings Per Share (EPS) was -0.47, with a year-on-year change of -40.88.
What is the net margin of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its net profit margin was -258.05, with a year-on-year change of -81.67.
What is the debt-to-asset ratio of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its debt-to-asset ratio was 14.16, with a year-on-year change of 38.12.
What is the Return on Equity (ROE) of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its Return on Equity (ROE) was -61.17, with a year-on-year change of -43.15.
What is the Return on Assets (ROA) of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its Return on Assets (ROA) was -30.05, with a year-on-year change of -65.54.
What is the operating profit of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its operating profit was -50.01M, with a year-on-year change of -51.22.